P. Birrer

4.1k citations

27 papers · 3.3k indexed · 2 hit papers · h-index 18

Impact in

Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Pulmonary and Respiratory Medicine top 1%
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research
- Inhalation and Respiratory Drug Delivery
- Tracheal and airway disorders

Papers in

Pulmonary and Respiratory Medicine 22
- Cystic Fibrosis Research Advances 17
- Neonatal Respiratory Health Research 15
- Inhalation and Respiratory Drug Delivery 13
- Tracheal and airway disorders 6
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Respiratory Support and Mechanisms 2
Anesthesiology and Pain Medicine 2

Co-authors: Ronald G. Crystal Noel G. McElvaney Keith C. Meyer K Botzenhart Ute Schwab Jürgen Berger Scott H. Randell Gerd Döring
Journals: Journal of Clinical Investigation (4 papers)Respiration (2 papers)European Respiratory Journal (2 papers)European Journal of Pediatrics (2 papers)Journal of Applied Physiology (2 papers)
Partner nations: Switzerland United States Germany

In The Last Decade

P. Birrer

27 papers receiving 3.2k citations

Hit Papers

align trajectories log scale

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients 2002 · 778 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 Journal of Clinical Investigation
2002 Journal of Clinical Investigation

Peers

Countries citing papers authored by P. Birrer

Since Specialization

Citations

This map shows the geographic impact of P. Birrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Birrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Birrer more than expected).

Fields of papers citing papers by P. Birrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Birrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Birrer. The network helps show where P. Birrer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside P. Birrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. Birrer Line = papers co-authored together P. Birrer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients Journal of Clinical Investigation ·Dieter Worlitzsch, Robert Tarran, Martina Ulrich, Ute Schwab, Людмила Михайлова, Keith C. Meyer, P. Birrer, G. Bellon, Jürgen Berger, Tilo Weiß, K Botzenhart, James R. Yankaskas, Scott H. Randell, Richard C. Boucher, Gerd Döring Hit paper breakdown →	2002	778
2	Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients Journal of Clinical Investigation ·Dieter Worlitzsch, Robert Tarran, Martina Ulrich, Ute Schwab, Людмила Михайлова, Keith C. Meyer, P. Birrer, G. Bellon, Jürgen Berger, Tilo Weiß, K Botzenhart, James R. Yankaskas, Scott H. Randell, Richard C. Boucher, Gerd Döring Hit paper breakdown →	2002	919
3	Inhalation of α1-Protease Inhibitor in Cystic Fibrosis does not affect Surfactant Convertase and Surface Activity Pulmonary Pharmacology & Therapeutics ·Matthias Griese, T. Siddiqui, P. Birrer, Andrea Schams	2001	8
4	Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled α1-protease inhibitor in cystic fibrosis Electrophoresis ·Matthias Griese, T. Siddiqui, P. Birrer	2001	42
5	Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis European Respiratory Journal ·T. Siddiqui, P. Birrer, Matthias Griese	2001	59
6	Bronchodilator responsiveness in a ventilator-dependent infant with severe tracheobronchomalacia Intensive Care Medicine ·Chas Scott, P. Birrer, Martin Tönz, H Tschäppeler, J. Pfenninger	1999	1
7	Genotype-Phenotype Association in Infants with Cystic Fibrosis at the Time of Diagnosis Pediatric Research ·Richard Kraemer, P. Birrer, Sabina Liechti‐Gallati	1998	25
8	Clinical and Physilological Improvement after Inhalation of Low-Dose Beclomethasone Dipropionate and Salbutamol in Wheezy Infants Respiration ·Richard Kraemer, Andreia Marinho BARBOSA, 郭碧坚, W.-S. Hou, P. Birrer	1997	38
9	Antipyretic Effect of Parenteral Paracetamol (Propacetamol) in Pediatric Oncologic Patients: A Randomized Trial Pediatric Hematology and Oncology ·Lucía Tecles Peydro, P. Birrer, Буров Владимир Андронович, Peter C. Rimensberger, Al M. Fagih	1997	4
10	Infection invasiveà Pseudomonas aeruginosa et Ecthyma gangrenosum chez un enfant sans facteurs de risques Archives de Pédiatrie ·C. Biino, B Frey, P. Birrer	1996	10
11	Proteases and Antiproteases in Cystic Fibrosis: Pathogenetic Considerations and Therapeutic Strategies Respiration ·P. Birrer	1995	46
12	Chronic Metabolic Alkalosis: Not Uncommon in Young Children with Severe Cystic Fibrosis American Journal of Nephrology ·K. Raka, Sabina Liechti‐Gallati, 马应良, P. Birrer, Richard Kraemer, �. M. Omel'yanovskii, Mario G. Bianchetti	1995	13
13	Mycobacterium genavense invasive infection in two children with AIDS: Long-term followup European Journal of Pediatrics ·Lucía Tecles Peydro, P. Birrer, Seyed Jamal Addin Gohari	1995	3
14	Protease-Antiprotease Imbalance in the Lungs of Children with Cystic Fibrosis American Journal of Respiratory and Critical Care Medicine ·P. Birrer, Noel G. McElvaney, A Rüdeberg, Mitsuru Nishiyama, Sabina Liechti‐Gallati, Richard Kraemer, Richard C. Hubbard, Ronald G. Crystal	1994	315
15	Consequences Of Unbalanced Protease in the Lung: Protease Involvement in Destruction and Local Defense Mechanisms of the Lung Birkhäuser Basel eBooks ·P. Birrer	1993	8
16	Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. Journal of Clinical Investigation ·Noel G. McElvaney, Hidenori Nakamura, P. Birrer, C A Hébert, W L Wong, P S Basil, J B Baker, Mariafrancesca Catalano, Ronald G. Crystal	1992	245
17	A Preliminary Study of Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic Fibrosis New England Journal of Medicine ·Richard C. Hubbard, Noel G. McElvaney, P. Birrer, Steven Shak, Timothy Dolch, 鄭哲源, Margaret Wu, Milica S. Chernick, Ronald G. Crystal	1992	158
18	A new baby-spacer device for aerosolized bronchodilator administration in infants with bronchopulmonary disease European Journal of Pediatrics ·Richard Kraemer, P. Birrer, Katharina Modelska, 郭碧坚, Martin H. Schöni	1992	33
19	Aerosol α1 -antitrypsin treatment for cystic fibrosis The Lancet ·Noel G. McElvaney, Richard C. Hubbard, P. Birrer, Ronald G. Crystal, Minh Vo QUANG, Martin Frank, Daniel B. Caplan	1991	252
20	Short-time response characteristics of salbutamol in infants with broncho-pulmonary diseases European Journal of Clinical Pharmacology ·Richard Kraemer, P. Birrer, Felix H. Sennhauser, Lisangela Veiga Trevisan	1988	10

About P. Birrer

P. Birrer is a scholar working on Pulmonary and Respiratory Medicine, Anesthesiology and Pain Medicine, Endocrine and Autonomic Systems, Molecular Medicine and Endocrinology, having authored 27 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (17 papers), Neonatal Respiratory Health Research (15 papers), Inhalation and Respiratory Drug Delivery (13 papers), Tracheal and airway disorders (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Respiratory Support and Mechanisms (2 papers), Neuroscience of respiration and sleep (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Molecular Medicine (388 citations), Pulmonary and Respiratory Medicine (2.2k citations), Endocrinology (276 citations), Microbiology (140 citations) and Emergency Medical Services (144 citations). P. Birrer has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Ronald G. Crystal, Noel G. McElvaney, Keith C. Meyer, K Botzenhart, Ute Schwab, Jürgen Berger, Scott H. Randell, Gerd Döring, Robert Tarran and James R. Yankaskas. Their work appears in journals such as Journal of Clinical Investigation, Respiration, European Respiratory Journal, European Journal of Pediatrics and Journal of Applied Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact